tiprankstipranks
Trending News
More News >
Silence Therapeutics (DE:XRP2)
FRANKFURT:XRP2
Germany Market

Silence Therapeutics (XRP2) Financial Statements

Compare
36 Followers

Silence Therapeutics Financial Overview

Silence Therapeutics's market cap is currently $285.85M. The company's EPS TTM is €-0.07814338289999999; its P/E ratio is -3.24; Silence Therapeutics is scheduled to report earnings on March 5, 2026, and the estimated EPS forecast is €-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue£ 559.00K£ 43.26M£ 25.38M£ 21.66M£ 12.41M
Gross Profit£ 344.00K£ 31.45M£ 15.06M£ 8.19M£ 4.96M
Operating Income£ -89.75M£ -63.32M£ -49.60M£ -61.04M£ -45.81M
EBITDA£ -60.80M£ -48.99M£ -49.78M£ -60.44M£ -45.42M
Net Income£ -88.61M£ -45.31M£ -43.27M£ -50.33M£ -39.41M
Balance Sheet
Cash & Short-Term Investments£ 85.11M£ 147.33M£ 68.79M£ 71.14M£ 73.54M
Total Assets£ 131.44M£ 202.63M£ 119.45M£ 107.50M£ 96.19M
Total Debt£ -160.00K£ 117.00K£ 346.00K£ 446.00K£ 137.00K
Net Debt£ -11.44M£ -121.21M£ -68.44M£ -54.37M£ -73.40M
Total Liabilities£ 51.31M£ 68.61M£ 97.45M£ 85.43M£ 87.67M
Stockholders' Equity£ 46.24M£ 134.02M£ 21.99M£ 22.07M£ 8.53M
Cash Flow
Free Cash Flow£ -62.33M£ -67.85M£ -39.40M£ -57.59M£ 7.39M
Operating Cash Flow£ -62.27M£ -67.64M£ -39.35M£ -57.04M£ 9.19M
Investing Cash Flow£ -35.70M£ -21.97M£ 16.43M£ -20.50M£ 11.71M
Financing Cash Flow£ 11.16K£ 142.09M£ 25.16M£ 52.58M£ 41.45M
Currency in GBP

Silence Therapeutics Earnings and Revenue History

Silence Therapeutics Debt to Assets

Silence Therapeutics Cash Flow

Silence Therapeutics Forecast EPS vs Actual EPS